“Inpharmatica, a bioinformatics and pharmaceutical research
company, announced on 14 December that it has more than doubled the
power of its in-house computer facilities.”
“Large amounts of computer power is essential for the techniques
involved in analysing the enormous amounts of data now generated by
the Human Genome Project. Inpharmatica’s 1100-processor Linux
system is claimed to be the most powerful commercial installation
in Europe dedicated to bioinformatics….”
“Historically, companies wanting to do large-scale,
processing-intensive computing have had to rely on specialist
high-performance computing vendors with high-cost proprietary
solutions,” said Pat Leach, IT director at Inpharmatica. “The use
of Linux and the low cost of standard PC components has enabled
Inpharmatica to achieve ‘more for less’.”